Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Infection|September 6, 2024
Plasma MERTK is causally associated with infection mortalityMichael Drozd, Fergus Hamilton, Chew W Cheng, et al.
Plos One|November 3, 2012
A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 yearsRichard D Antrobus, Patrick J Lillie, Tamara K Berthoud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1Tamara K Berthoud, Matthew Hamill, Patrick J Lillie, et al.
Clinical and Translational Science|August 14, 2012
Incidental diagnosis in healthy clinical trial subjectsChristopher J A Duncan, Rosalind Rowland, Patrick J Lillie, et al.
Epidemiology and Infection|August 29, 2020
COVID-19: public health management of the first two confirmed cases identified in the UKB Holden, A Quinney, S Padfield, et al.
Cancer Research|August 2, 2001
Genetic analysis of early- versus late-stage ovarian tumorsV Shridhar, J Lee, A Pandita, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2012
Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humansPatrick J Lillie, Tamara K Berthoud, Timothy J Powell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humansSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Pageof 5